Cx Precision Medicine: Funding, Investors & Team (Oct 2026)
Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents. Our lead products are focused on neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementia-causing disorders. Our low-cost and non-invasive tests will rule out Alzheimer’s disease and Parkinson’s disease for many and help identify others who will benefit from more comprehensive testing. Our test will also help physicians treat patients with the right medicines more quickly.
Cx Precision Medicine has raised $1.2M across 1 funding round on record, the most recent an undisclosed round of $1.2M announced in Dec 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cx Precision Medicine Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Cx Precision Medicine Funding Rounds
Cx Precision Medicine Founders and Leadership Team
No contact details are on record for this team yet.
Cx Precision Medicine Funding Compared to Other Biotechnology Startups
Cx Precision Medicine's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cx Precision Medicine in Biotechnology and Fort Worth
Companies Similar to Cx Precision Medicine
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Cx Precision Medicine Funding FAQs
What does Cx Precision Medicine do?
Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents. Our lead products are focused on neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementia-causing disorders. Our low-cost and non-invasive tests will rule out Alzheimer’s disease and Parkinson’s disease for many and help identify others who will benefit from more comprehensive testing. Our test will also help physicians treat patients with the right medicines more quickly.
How much funding has Cx Precision Medicine raised?
Cx Precision Medicine has raised $1.2M across 1 round on record. The most recent is an undisclosed round of $1.2M announced in Dec 2022.
When did Cx Precision Medicine last raise funding?
Cx Precision Medicine's most recent funding round on record is an undisclosed round of $1.2M, announced in Dec 2022.
Who founded Cx Precision Medicine?
FundedIQ lists Sid Obryant (Founder) at Cx Precision Medicine.
Where is Cx Precision Medicine headquartered?
Cx Precision Medicine is based in Fort Worth, Texas, United States.
How many employees does Cx Precision Medicine have?
Cx Precision Medicine is in the 1-10 employee band.
How does Cx Precision Medicine's funding compare to other Biotechnology startups?
Cx Precision Medicine's latest round of $1.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cx Precision Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cx Precision Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.